Erratum to “Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1283-1287](S2468024925000506)(10.1016/j.ekir.2025.01.025)

Document Type

Article

Publication Title

Kidney International Reports

Abstract

In the original published version of this article, the following errors were introduced during the copyediting process by the Suppliers. The text originally published “Thus, trials requiring long follow-up periods are expensive and not feasible.” Has been corrected to “Thus, trials required long follow-up, were expensive, with limited feasibility.” The text originally published “As the risk threshold increased, the eGFR slope in the placebo arm also increased, resulting in improved study power.” Has been corrected to “As the risk threshold increases, the eGFR slope in the placebo arm would be faster resulting in improved study power.” The text originally published “This study was supported by grants from the First Research Call and the Immunonephrology Working Group of the European Renal Association, European Dialysis and Transplant Association.” Has been corrected to “The VALIGA study was supported by grants from the First Research Call and the Immunonephrology Working Group of the European Renal Association, European Dialysis and Transplant Association.” These errors bear no reflection on the article or its authors. The publisher apologizes to the authors and the readers for this unfortunate error. DOI of original article: https://doi.org/10.1016/j.ekir.2025.01.025

First Page

2506

DOI

10.1016/j.ekir.2025.05.026

Publication Date

7-1-2025

This document is currently not available here.

Share

COinS